≥98% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
🌡
Storage & shipping
Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
📋
Quality documents
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
📚
Literature proof
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Panoramica
BM-1244 (APG-1252-M1) is a potent Bcl-xL / Bcl-2 inhibitor with K i s of 134 and 450 nM for Bcl- xL and Bcl-2 , respectively. BM-1244 inhibits senescent fibroblasts (SnCs) with an EC 50 of 5 nM. (From patent WO2019033119A1).
Form:Solid
Specifications
Specifiche e purezza
≥98%
Meccanismi biochimici e fisiologici
BM-1244 (APG-1252-M1) is a potent Bcl-xL / Bcl-2 inhibitor with K i s of 134 and 450 nM for Bcl- xL and Bcl-2 , respectively. BM-1244 inhibits senescent fibroblasts (SnCs) with an EC 50 of 5 nM. (From patent WO2019033119A1).
Condizioni di conservazione di stoccaggio
Store at -20°C
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Tipo di azione
INHIBITOR
Purezza
≥98%
Nomi e identificatori
Peso molecolare
1159.79
Documentazione
📋 Safety Data Sheet (SDS)
Comprehensive hazard, handling, storage, and regulatory compliance document.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.